What Happens When You Stop Ozempic or Mounjaro? The Science of Weight Regain and How to Prevent It

By Ali Araghi, MD
Board-Certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, Sleep Medicine, and Obesity Medicine
Auria Medical Clinics | October 2026

---

Losing weight with medications like Ozempic or Mounjaro can be remarkable. Keeping it off may be the real challenge.

Imagine losing 40 pounds after months of treatment with a GLP-1-based medication. Your appetite has decreased, your cravings have quieted, and for the first time in years, controlling your portions feels almost effortless.

Then you stop the medication.

Within weeks or months, your hunger returns. Food occupies more of your thoughts. Gradually, the weight begins to creep back.

What happened? Did your willpower disappear?

No. Your biology has changed again.

The latest clinical research reveals why weight regain after discontinuing obesity medications is so commo and why longterm success requires more than medication alone.

Why It Matters

The big picture: Obesity is a chronic, biologically regulated condition, not simply the consequence of poor choices or lack of discipline.

Modern obesity medications can produce substantial weight loss, but discontinuing treatment often allows the biological forces that promote weight regain to reemerge.

The evidence is compelling:

• In the STEP 1 extension study, participants who discontinued semaglutide 2.4 mg and structured lifestyle treatment regained approximately two-thirds of their previous weight loss within one year.

• In the SURMOUNT-4 trial, participants who stopped tirzepatide regained an average of 14% of their body weight over the following 52 weeks, measured from the point of treatment withdrawal.

• The American Diabetes Association's 2026 guidance recognizes obesity as a chronic, relapsing condition that often requires ongoing treatment.

The bottom line: Losing weight is an achievement. Maintaining that weight loss requires a long-term strategy that addresses biology, nutrition, physical activity, habits, and behavior.

---

The Deep Dive

1. How Do GLP-1 Medications Help You Lose Weight?

The key: These medications do more than reduce appetite. They influence the biological systems that regulate hunger, fullness, and food intake.

GLP-1 (glucagon-like peptide-1) is a hormone released by the intestine after eating. It helps regulate insulin secretion, slows gastric emptying, and communicates with the brain's appetite-regulating circuits.

Semaglutide, used in Wegovy and Ozempic, activates the GLP-1 receptor. Tirzepatide, used in Zepbound and Mounjaro, activates both GLP-1 and GIP receptors.

Their effects include:

• Reduced hunger: Appetite-regulating pathways in the brain become less responsive to hunger signals.

• Earlier satiety: Patients often feel satisfied after eating smaller portions.

• Reduced food preoccupation: Some patients experience a decrease in persistent thoughts about food, often described as food noise.

• Improved metabolic regulation: Depending on the medication and the patient's underlying conditions, treatment can improve glucose regulation and other cardiometabolic risk factors.

These medications can make healthier eating easier to sustain.

But they do not permanently eliminate the biological susceptibility to obesity.

2. Why Does Hunger Return When Treatment Stops?

The surprising truth: Your brain actively participates in defending body weight.

The hypothalamus and interconnected brain networks continuously integrate hormonal, nutritional, and environmental signals to regulate energy intake and expenditure.

Following substantial weight loss, several biological adaptations may occur:

Appetite-promoting signals increase. Hormonal changes after weight loss can make food seem more appealing and hunger more persistent.

Energy expenditure may decrease. As body mass declines, the body generally requires fewer calories. Additional metabolic adaptation can sometimes occur beyond what would be expected from the smaller body size.

The medication's appetite-suppressing effects fade. As semaglutide or tirzepatide clears from the body, its influence on hunger and satiety progressively diminishes.

Previously learned habits remain. Food-associated cues, emotional eating patterns, and automatic routines may reappear, particularly during periods of stress or fatigue.

The result is a mismatch: The body may be biologically encouraging greater food intake while requiring fewer calories than before weight loss.

This helps explain why maintaining a lower weight can feel considerably more difficult than reaching it.

3. What Does the Scientific Evidence Tell Us?

Two landmark clinical studies illustrate the challenge.

Semaglutide: The STEP 1 extension

Participants receiving semaglutide lost an average of 17.3% of their starting body weight during 68 weeks of treatment.

One year after discontinuing both medication and structured lifestyle intervention, they had regained an average of 11.6 percentage points of their original body weight - approximately two-thirds of the weight previously lost.

Many cardiometabolic improvements also moved back toward their pretreatment levels.

Tirzepatide: The SURMOUNT-4 trial

After 36 weeks of tirzepatide treatment, participants achieved an average weight reduction of 20.9%.

During the following 52 weeks:

• Those continuing tirzepatide lost another 5.5%, on average.

• Those switched to placebo regained approximately 14.0%.

These percentages describe changes relative to body weight at the study's randomization point.

Clinical pearl: These studies demonstrate that obesity medications often function as long-term disease management therapies rather than short courses that permanently reset body weight.

Importantly, these studies do not prove that behavioral interventions are ineffective. They show that biological pressures to regain weight can remain powerful even after successful treatment.

4. Should You Stay on GLP-1 Medications Forever?

Not necessarily - but stopping should be a planned medical decision.

For many patients, continued treatment may provide the best chance of maintaining weight loss and preserving improvements in metabolic health.

However, long-term treatment decisions depend on several factors:

• The degree of weight loss achieved and its health benefits

• Medication tolerance and adverse effects

• Medical conditions such as diabetes, cardiovascular disease, or obstructive sleep apnea

• Cost, insurance coverage, and medication availability

• Personal preferences and treatment goals

Some patients may continue medication at an individualized maintenance dose. Others may need to discontinue treatment because of adverse effects, cost, pregnancy planning, or other medical considerations.

For those stopping treatment, closer monitoring and a structured maintenance program become especially important.

There is no universally validated tapering protocol that guarantees prevention of weight regain.

The takeaway: Discuss any medication change with your treating clinician. Stopping medication without a follow-up plan can make weight maintenance more difficult.

5. Five Strategies That Can Help Maintain Weight Loss

The opportunity: The period during successful medication-assisted weight loss can become a valuable time to establish habits that support lasting health.

First: Protect your muscle mass.

Weight loss can involve reductions in both fat and lean tissue. Resistance training and adequate dietary protein can help preserve muscle mass, physical function, and strength.

Second: Build a sustainable eating pattern.

Rather than pursuing another restrictive diet, establish repeatable meals centered on vegetables, fiber-rich foods, sufficient protein, and minimally processed ingredients.

Third: Make physical activity a routine.

Regular aerobic activity and strength training support cardiometabolic health and weight maintenance. Choose activities that are realistic enough to continue for years, not just weeks.

Fourth: Monitor your progress without becoming obsessed with the scale.

Periodic weight measurements, waist circumference, activity tracking, and attention to returning hunger patterns may help identify weight regain early.

Fifth: Continue medical follow-up.

Regular appointments allow reassessment of nutrition, physical activity, medications, blood pressure, glucose, sleep, and other weight-related conditions.

Important distinction: These strategies are valuable components of obesity management, but none guarantees prevention of weight regain after GLP-1 medication withdrawal. Some patients will continue to need medication or other medical interventions despite meaningful lifestyle improvements.

6. The Missing Ingredient: From Weight Loss to Permanent Behavior Change

Here is the deeper question: Why do we so often fail to do what we already know is good for us?

Most people struggling with weight management already know that eating more vegetables, limiting highly processed foods, exercising regularly, and sleeping adequately are beneficial.

Yet knowledge alone rarely produces lasting behavioral change.

The explanation lies partly in neuroscience.

Our daily decisions are influenced by interacting brain systems involved in reward, motivation, habits, emotional regulation, and executive control.

When we repeatedly eat certain foods in response to stress, boredom, or environmental cues, those behaviors can become automatic. The brain learns to associate particular situations with expected rewards.

Changing these patterns requires more than receiving information. It requires repetition, a supportive environment, practical planning, and the gradual development of new automatic responses.

GLP-1-based medications may provide an opportunity to practice these behaviors while appetite and cravings are better controlled.

For example, instead of simply eating less while taking medication, a patient can learn to plan meals, recognize emotional eating triggers, develop a consistent exercise routine, and respond differently to food-related cues.

Over time, these actions can become more natural and require less deliberate effort.

A crucial distinction: Behavior change is not a substitute for the biological treatment of obesity. The strongest long-term strategy often combines behavioral and medical approaches.

7. From Knowing to Behaving: Understanding the Science of Lasting Change

I explored this fascinating relationship between knowledge, belief, the brain, and everyday behavior in my book:

FROM KNOWING TO BEHAVING: How Understanding the Science of Habits Can Help You Lose and Maintain a Healthy Weight

The book begins with a deceptively simple question:

If we know what is good for us, and genuinely believe it, why don't we consistently act on that knowledge?

Drawing on neuroscience, psychology, and the science of habit formation, it explores how our brains translate information into motivation, how repeated behaviors become automatic, and how deliberate changes can gradually become part of our identity.

It also provides practical exercises to help readers recognize their own behavioral patterns, identify obstacles, and build sustainable habits.

The central message is that knowledge is where change begins, but consistent behavior is what makes change last.

For patients taking GLP-1 medications - or anyone trying to improve their weight and metabolic health - understanding this process can be an important part of a comprehensive long-term strategy.

Interested in learning more?

📖 Get From Knowing to Behaving on Amazon Kindle

8. A Final Thought: Treat the Disease, Train the Habits

Obesity medications have transformed our ability to help patients lose weight.

But the success of weight management should not be measured only by how many pounds disappear while taking a medication.

It should also be measured by improvements in health, physical function, quality of life, and the ability to sustain beneficial habits.

For some patients, long-term medication will remain necessary. For others, a carefully structured transition may be possible.

The ultimate goal is not simply to lose weight. It is to build a healthier life - and develop the tools, habits, and medical support needed to sustain it.

---

The Pearl

Medication can help quiet the hunger. Behavior change helps build the habits. Long-term medical care addresses the biology that may remain.

Together, they provide a more comprehensive approach to lasting weight management.

---

About Auria Medical Clinics

At Auria Medical Clinics, we approach obesity as a chronic medical condition requiring individualized, evidence-based treatment.

Our weight management program integrates medical evaluation, appropriate pharmacotherapy, nutritional guidance, behavioral strategies, and long-term follow-up.

We also recognize the close relationship between obesity and conditions such as diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea.

Ready to develop a sustainable weight management plan?

Visit www.auriaclinics.com to learn more about our services and request an appointment.

Auria Medical Clinics - Suwanee, Georgia.

---

References and Further Reading

1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553–1564. Read the study.

2. Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA. 2024;331:38–48. Read the study.

3. American Diabetes Association. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes - 2026. Diabetes Care. Read guidelines.

4. American Diabetes Association. Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity - 2026. Read guidelines.

5. Araghi A. From Knowing to Behaving: How Understanding the Science of Habits Can Help You Lose and Maintain a Healthy Weight. Amazon Kindle.

Medical disclaimer: This article is intended for general educational purposes and is not a substitute for individualized medical advice. Medication decisions should be made in consultation with a qualified healthcare professional.